Clinical Resources
- Unit Competency
- Reference Sheets, Float/Registry Staff
Hematology/BMT/Oncology (11L, 12S, 12L, L14)
Adult BMT site
- Alemtuzumab (Campath)
- Ambisome
- Antiemetics
- ARA-C
- Arsenic Trioxide (Trisenox)
- ATG
- Autologous Transplant Discharge Instructions
- Autologous Stem Cell Discharge Instructions
- Blood Product administration in BMT context
- Bone Marrow Cyopreservered Progenitor Cell Infusion
- Donor Evaluation and Management Allogeneic Hematopoietic Cell Donation
- Patient Evaluation and Management Autologous Hematopoietic Cell Donation
- Preparation, Infusion and Monitoring of Hematopoietic Cell Infusions
- Busulfan
- Intravenous Busulfan Administration
- Busulfan Blood Levels
- Chemotherapy Administration/ Orders
- Administration of the BMT Preparative Regimen
- Chemotherapy and Hazardous Medications
- Cidovir
- Cisplatin
- CMV Prophylaxis and Treatment
- Cyclosporin
- Cytoxan/ Mesna
- Daclizumab
- Daunorubicin
- Decitabine
- Denileukin (Ontak)
- Etoposide
- High Dose Etoposide
- Low to Moderate Dose Etoposide
- G-CSF/ GM-CSF
- Graft v Host Disease
- Sinusoidal Occlusion Syndrome
GVHD Prevention
GVHD Treatment
- Graft v Host Disease (GVHD) Prophylaxis
- Acute Graft v Host Disease (aGVHD)
- Chronic Graft v Host Disease (cGVHD)
- Hepatic Chemoembolization
- Ifosfamide & Doxorubicin/Epirubicin (Sarcoma)
- L-asparaginase
- Mercaptopurine (6 MP)
- Methotrexate
- High Dose 36 hr Methotrexate
- Methotrexate Immunosuppressant
- High Dose 4 hour Methotrexate
- Mouth Care Protocol
- Mucositis
- Pulmonary Complications
- Rituximab (Rituxan)
- Sepsis
- Pulmonary Toxicity Management
- Sinusoidal Occlusion Syndrome
- Hemorrhagic Cystitis
- Mucositis
- Management of Nausea and Vomiting
- Skin Care Protocol (page 11)
- Tacrolimus (FK-506)
- Taxol
- Total Body Irradiation TBI
- Thiotepa
- Tretinoin (ATRA, Vesanoid)
- Yttrium 90